Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Acta Cardiol. 2021 Dec;76(10):1043-1051. doi: 10.1080/00015385.2020.1801197. Epub 2020 Aug 5.
To chart the evolution of the CTO-PCI landscape in Belgium and Luxembourg, the Belgian Working Group on Chronic Total Occlusions (BWGCTO) was established in 2016.
Between May 2016 and December 2019, patients undergoing a CTO-PCI treatment were prospectively and consecutively enrolled. Twenty-one centres in Belgium and one in Luxembourg participated. Individual operators had mixed levels of expertise in treating CTO lesions. Demographic, angiographic, procedural parameters and incidence of major adverse cardiac and cerebrovascular events (MACCE) were systematically registered.
Over a four-year enrolment period, 1832 procedures were performed in 1733 patients achieving technical success in 1474 cases (80%), with an in-hospital MACCE rate of 2.3%. Fifty-nine (3%) cases were re-attempt procedures of which 41 (69%) were successful. High-volume centres treated more complex lesions (mean J-CTO score: 2.15 ± 1.21) as compared to intermediate (mean J-CTO score: 1.72 ± 1.23; < 0.001) and low-volume centres (mean J-CTO score: 0.99 ± 1.21; = 0.002). Despite this, success rates did not differ between centres ( = 0.461). Overall success rates did not differ over time ( = 0.810). High-volume centres progressively tackled more complex CTOs while keeping success rates stable. In all centres, the most applied strategy was antegrade wire escalation (83%). High-volume centres more often successfully applied antegrade dissection and re-entry and retrograde techniques in lesions with higher complexity.
With variable experience levels, operators treated CTOs with high success and relatively few complications. Although AWE remains the most used technique, it is paramount for operators to be skilled in all contemporary techniques in order to be successful in more complex CTOs.
为了描绘比利时和卢森堡的 CTO-PCI 治疗现状,比利时慢性完全闭塞工作组(BWGCTO)于 2016 年成立。
2016 年 5 月至 2019 年 12 月,前瞻性连续纳入行 CTO-PCI 治疗的患者。比利时的 21 个中心和卢森堡的 1 个中心参与了该研究。每位术者对 CTO 病变的处理都有不同程度的专业知识。系统登记了患者的人口统计学、血管造影、手术参数和主要不良心脑血管事件(MACCE)的发生率。
在四年的登记期间,共对 1733 例患者的 1832 例次 CTO 病变进行了治疗,其中 1474 例次(80%)达到了技术成功,住院期间的 MACCE 发生率为 2.3%。59 例(3%)进行了再次尝试,其中 41 例(69%)成功。高容量中心治疗的病变更复杂(平均 J-CTO 评分:2.15±1.21),而中容量中心(平均 J-CTO 评分:1.72±1.23; <0.001)和低容量中心(平均 J-CTO 评分:0.99±1.21; = 0.002)治疗的病变更简单。尽管如此,各中心之间的成功率没有差异( = 0.461)。总体成功率随时间推移没有差异( = 0.810)。高容量中心逐渐处理更复杂的 CTO,同时保持稳定的成功率。在所有中心,最常应用的策略是正向导丝升级(83%)。高容量中心更常成功地应用正向夹层和再进入技术和逆行技术治疗复杂程度更高的病变。
术者在不同的经验水平下,成功地治疗了 CTO 病变,并发症发生率相对较低。虽然正向导丝升级仍然是最常用的技术,但术者掌握所有当代技术至关重要,以便在更复杂的 CTO 病变中获得成功。